Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R. Nevin Murray"'
Publikováno v:
European Urology. 67:23-29
Background The activity of enzalutamide after prior treatment with both abiraterone acetate (abiraterone) and docetaxel has been examined in several retrospective studies. However, limited data are available on the efficacy of enzalutamide following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a05147f0d11cfed3a2f54cf70eb5c2
https://doi.org/10.1016/j.eururo.2014.06.045
https://doi.org/10.1016/j.eururo.2014.06.045
Autor:
D.Y.C. Heng, Arun Azad, Renee Lester, Bernhard J. Eigl, Anthony M. Joshua, Christian Kollmannsberger, Raya Leibowitz-Amit, Kim N. Chi, J. Connor Wells, R. Nevin Murray
Publikováno v:
The Prostate. 74:1544-1550
BACKGROUND Questions about optimal sequencing of systemic therapy in metastatic castration-resistant prostate cancer (mCRPC) and whether cross-resistance occurs between different drugs remain largely unanswered. Previous studies have produced conflic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bce62c2f4b16faa8293a72b1f715d168
https://doi.org/10.1002/pros.22872
https://doi.org/10.1002/pros.22872
Autor:
Christina Canil, Eric Winquist, Anna V. Tinker, Malcolm A.S. Moore, Kim N. Chi, R. Nevin Murray
Publikováno v:
American Journal of Clinical Oncology. 29:3-7
Objective: Efficacious regimens are needed for the treatment of metastatic bladder cancer. The aim of this study was to determine the toxicity and phase II dose of a triplet regimen of cisplatin, gemcitabine, and weekly docetaxel for patients with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f697aca0713e1514469626ee162e04a8
https://doi.org/10.1097/01.coc.0000200044.81711.57
https://doi.org/10.1097/01.coc.0000200044.81711.57
Autor:
Arun A, Azad, Raya, Leibowitz-Amit, Bernhard J, Eigl, Renee, Lester, J Connor, Wells, R Nevin, Murray, Christian, Kollmannsberger, Daniel Y C, Heng, Anthony M, Joshua, Kim N, Chi
Publikováno v:
The Prostate. 74(15)
Questions about optimal sequencing of systemic therapy in metastatic castration-resistant prostate cancer (mCRPC) and whether cross-resistance occurs between different drugs remain largely unanswered. Previous studies have produced conflicting data o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4b301f8d96a46af610fa1557c38aa6ca
https://pubmed.ncbi.nlm.nih.gov/25175831
https://pubmed.ncbi.nlm.nih.gov/25175831
Autor:
Peter M. Ellis, Colum Smith, R. Nevin Murray, Glenwood D. Goss, Frank Beier, Charles Butts, Guy Ely, Andrew Maksymiuk, Denis Soulières, Kevin Jasas
Publikováno v:
Clinical lung cancer. 11(6)
Introduction: BLP25 liposome vaccine (L-BLP25) is an innovative therapeutic cancer vaccine designed to induce an immune response resulting in elimination of tumor cells expressing the MUC1 antigen, which is overexpressed in non–small-cell lung canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7e9668b3b0eebcf524a30aca014b4d
https://pubmed.ncbi.nlm.nih.gov/21071331
https://pubmed.ncbi.nlm.nih.gov/21071331